← Back to headlines
Leerink Partners Lifts Price Target on Oruka Therapeutics
Leerink Partners has raised its price target on Oruka Therapeutics, Inc. (ORKA), indicating a positive outlook for the company's stock.
10 May, 23:13 — 10 May, 23:13
Sources
Showing 1 of 1 sources
